Skip to main content

Brain Imaging of Ketamine Abusers

  • Chapter
  • First Online:
Ketamine
  • 851 Accesses

Abstract

In this chapter, we highlight the role of brain imaging techniques (e.g., magnetic resonance imaging [MRI]) in studying ketamine abuse. In the past two to three decades, brain imaging studies demonstrated deficits in brain circuits related to drug addiction and drug abuse. This chapter begins with a brief introduction of structural and functional brain imaging techniques such as computed tomography (CT) and electroencephalogram (EEG). Then, we give a brief introduction of ketamine abuse in mainland China before introducing structural MRI and functional MRI and reviewing the application of structural MRI study for ketamine abusers (including reduction of gray matter volume and disruption of white matter integrity) and functional MRI study for ketamine abusers (including alternation of regional homogeneity (ReHo) of resting-state brain activity, functional connectivity by resting-state fMRI, task-based fMRI). Finally, we discuss the implication for medical use of ketamine by brain imaging study, especially its rapid-acting glutamatergic antidepressant effects and the “ketamine model” of psychosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012) Ketamine for depression: where do we go from here? Biol Psychiatry 72:537–547

    Article  CAS  Google Scholar 

  • Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY (2017) Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology 42:1210

    Article  CAS  PubMed  Google Scholar 

  • Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL, Brady TJ (1990) Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 14:538–546

    Article  CAS  PubMed  Google Scholar 

  • Biswal B, Zerrin Yetkin F, Haughton VM, Hyde JS (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34:537–541

    Article  CAS  PubMed  Google Scholar 

  • Bonnet U (2015) Long-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine’s antidepressant response and the development of ketamine addiction. J Psychoactive Drugs 47:276–285

    Article  PubMed  Google Scholar 

  • Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 45:1542–1552

    Article  CAS  PubMed  Google Scholar 

  • Canu E, Agosta F, Filippi M (2015) A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease. Schizophr Res 161:19–28

    Article  PubMed  Google Scholar 

  • Cartwright P, Pingel S (1984) Midazolam and diazepam in ketamine anaesthesia. Anaesthesia 39:439–442

    Article  CAS  PubMed  Google Scholar 

  • Casey BJ, Tottenham N, Liston C, Durston S (2005) Imaging the developing brain: what have we learned about cognitive development? Trends Cogn Sci 9:104–110

    Article  CAS  PubMed  Google Scholar 

  • Chan KW, Lee TM, Siu AM, Wong DP, Kam C-M, Tsang SK, Chan CC (2013) Effects of chronic ketamine use on frontal and medial temporal cognition. Addict Behav 38:2128–2132

    Article  PubMed  Google Scholar 

  • Clarke K, Hall L (1990) A survey of anaesthesia in small animal practice: AVA/BSAVA report. J Assoc Vet Anaesth Great Britain Ireland 17:4–10

    Article  Google Scholar 

  • Deakin JW, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM (2008) Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco–magnetic resonance imaging study. Arch Gen Psychiatry 65:154–164

    Article  PubMed  Google Scholar 

  • Elia N, Tramèr MR (2005) Ketamine and postoperative pain—a quantitative systematic review of randomised trials. Pain 113:61–70

    Article  CAS  PubMed  Google Scholar 

  • Ezquerra-Romano II, Lawn W, Krupitsky E, Morgan C (2018) Ketamine for the treatment of addiction: evidence and potential mechanisms. Neuropharmacology 142:72–82

    Article  CAS  Google Scholar 

  • Fang YX, Wang YB, Shi J, Liu ZM, Lu L (2006) Recent trends in drug abuse in China. Acta Pharmacol Sin 27:140–144

    Article  CAS  PubMed  Google Scholar 

  • Fedota JR, Stein EA (2015) Resting-state functional connectivity and nicotine addiction: prospects for biomarker development. Ann N Y Acad Sci 1349:64

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fleisher AS, Sherzai A, Taylor C, Langbaum JB, Chen K, Buxton RB (2009) Resting-state BOLD networks versus task-associated functional MRI for distinguishing Alzheimer’s disease risk groups. Neuroimage 47:1678–1690

    Article  PubMed  Google Scholar 

  • Fouche J-P, Du Plessis S, Hattingh C, Roos A, Lochner C, Soriano-Mas C, Sato JR, Nakamae T, Nishida S, Kwon JS (2017) Cortical thickness in obsessive–compulsive disorder: multisite mega-analysis of 780 brain scans from six centres. Br J Psychiatry 210:67–74

    Article  PubMed  Google Scholar 

  • Goldstein RZ, Volkow ND (2011) Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12:652

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Green SM, Johnson NE (1990) Ketamine sedation for pediatric procedures: part 2, review and implications. Ann Emerg Med 19:1033–1046

    Article  CAS  PubMed  Google Scholar 

  • Hibar D, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I (2016) Subcortical volumetric abnormalities in bipolar disorder. Mol Psychiatry 21:1710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hirsch GV, Bauer CM, Merabet LB (2015) Using structural and functional brain imaging to uncover how the brain adapts to blindness. Ann Neurosci Psychol 2:5

    PubMed  PubMed Central  Google Scholar 

  • Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB (1999) Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 42:849–863

    Article  CAS  PubMed  Google Scholar 

  • Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496–11500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Honey G, Bullmore E (2004) Human pharmacological MRI. Trends Pharmacol Sci 25:366–374

    Article  CAS  PubMed  Google Scholar 

  • Honey GD, Corlett PR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Bullmore ET, Menon DK, Fletcher PC (2008) Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J Neurosci 28:6295–6303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hong S-B, Zalesky A, Cocchi L, Fornito A, Choi E-J, Kim H-H, Suh J-E, Kim C-D, Kim J-W, Yi S-H (2013) Decreased functional brain connectivity in adolescents with internet addiction. PLoS One 8:e57831

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jenike MA, Breiter HC, Baer L, Kennedy DN, Savage CR, Olivares MJ, O’Sullivan RL, Shera DM, Rauch SL, Keuthen N (1996) Cerebral structural abnormalities in obsessive-compulsive disorder: a quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 53:625–632

    Article  CAS  PubMed  Google Scholar 

  • Katalinic N, Lai R, Somogyi A, Mitchell PB, Glue P, Loo CK (2013) Ketamine as a new treatment for depression: a review of its efficacy and adverse effects. Aust N Z J Psychiatry 47:710–727

    Article  PubMed  Google Scholar 

  • Kokkinou M, Ashok AH, Howes OD (2017) The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders. Mol Psychiatry 23:59

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Krystal JH, Sanacora G, Duman RS (2013) Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73:1133–1141

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R (1992) Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci 89:5675–5679

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia. Ann N Y Acad Sci 1003:138–158

    Article  CAS  PubMed  Google Scholar 

  • Lauterbur PC (1973) Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242:190–191

    Article  CAS  Google Scholar 

  • Li C-SR, Zhang S, Hung C-C, Chen C-M, Duann J-R, Lin C-P, Lee TS-H (2017a) Depression in chronic ketamine users: sex differences and neural bases. Psychiatry Res Neuroimaging 269:1–8

    Article  PubMed  Google Scholar 

  • Li Q, Shi L, Lu G, Yu H-L, Yeung F-K, Wong N-K, Sun L, Liu K, Yew D, Pan F (2017b) Chronic ketamine exposure causes white matter microstructural abnormalities in adolescent cynomolgus monkeys. Front Neurosci 11:285

    Article  PubMed  PubMed Central  Google Scholar 

  • Liao Y, Tang J, Ma M, Wu Z, Yang M, Wang X, Liu T, Chen X, Fletcher PC, Hao W (2010) Frontal white matter abnormalities following chronic ketamine use: a diffusion tensor imaging study. Brain 133:2115–2122

    Article  PubMed  Google Scholar 

  • Liao Y, Tang J, Corlett PR, Wang X, Yang M, Chen H, Liu T, Chen X, Hao W, Fletcher PC (2011) Reduced dorsal prefrontal gray matter after chronic ketamine use. Biol Psychiatry 69:42–48

    Article  CAS  PubMed  Google Scholar 

  • Liao Y, Tang J, Fornito A, Liu T, Chen X, Chen H, Xiang X, Wang X, Hao W (2012) Alterations in regional homogeneity of resting-state brain activity in ketamine addicts. Neurosci Lett 522:36–40

    Article  CAS  PubMed  Google Scholar 

  • Liao Y, Qi C, Wu Q, Tang J (2016a) Psychiatric symptoms in individuals who use ketamine versus methamphetamine—implications for glutamatergic and dopaminergic model for schizophrenia: a cohort study. Lancet 388:S67

    Article  Google Scholar 

  • Liao Y, Tang J, Liu J, Xie A, Yang M, Johnson M, Wang X, Deng Q, Chen H, Xiang X (2016b) Decreased thalamocortical connectivity in chronic ketamine users. PLoS One 11:e0167381

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Liao Y, Tang Y-l, Hao W (2017) Ketamine and international regulations. Am J Drug Alcohol Abuse 43:495–504

    Article  PubMed  Google Scholar 

  • Liao Y, Johnson M, Qi C, Wu Q, Xie A, Liu J, Yang M, Huang M, Zhang Y, Liu T (2018) Cue-induced brain activation in chronic ketamine-dependent subjects, cigarette smokers, and healthy controls: a task functional magnetic resonance imaging study. Front Psych 9:88

    Article  Google Scholar 

  • Liu Y, Lin D, Wu B, Zhou W (2016) Ketamine abuse potential and use disorder. Brain Res Bull 126:68–73

    Article  CAS  PubMed  Google Scholar 

  • Mansfield P, Maudsley AA (1977) Medical imaging by NMR. Br J Radiol 50:188–194

    Article  CAS  PubMed  Google Scholar 

  • Michels II, Fang Y-x, Zhao D, Zhao L-y, Lu L (2007) Comparison of drug abuse in Germany and China. Acta Pharmacol Sin 28:1505

    Article  CAS  PubMed  Google Scholar 

  • Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921–2927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morgan CJ, Curran HV (2006) Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology (Berl) 188:408–424

    Article  CAS  Google Scholar 

  • Morgan CJ, Monaghan L, Curran HV (2004a) Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug. Addiction 99:1450–1461

    Article  PubMed  Google Scholar 

  • Morgan CJ, Riccelli M, Maitland CH, Curran HV (2004b) Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. Drug Alcohol Depend 75:301–308

    Article  CAS  PubMed  Google Scholar 

  • Morgan CJ, Curran HV, Drugs ISC o (2012) Ketamine use: a review. Addiction 107:27–38

    Article  PubMed  Google Scholar 

  • Narendran R, Frankle WG, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang D-R (2005) Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 162:2352–2359

    Article  PubMed  Google Scholar 

  • Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 87:9868–9872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Parvaz MA, Alia-Klein N, Woicik PA, Volkow ND, Goldstein RZ (2011) Neuroimaging for drug addiction and related behaviors. Rev Neurosci 22:609–624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roberts RE, Curran HV, Friston KJ, Morgan CJ (2014) Abnormalities in white matter microstructure associated with chronic ketamine use. Neuropsychopharmacology 39:329

    Article  CAS  Google Scholar 

  • Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249–265

    Article  CAS  PubMed  Google Scholar 

  • Rosenblat JD, Carvalho AF, Li M, Lee Y, Subramanieapillai M, McIntyre RS (2019) Oral ketamine for depression: a systematic review. J Clin Psychiatry 80:18r12475

    Article  PubMed  Google Scholar 

  • Rowland LM, Bustillo JR, Mullins PG, Jung RE, Lenroot R, Landgraf E, Barrow R, Yeo R, Lauriello J, Brooks WM (2005) Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry 162:394–396

    Article  PubMed  Google Scholar 

  • Rowland LM, Beason-Held L, Tamminga CA, Holcomb HH (2010) The interactive effects of ketamine and nicotine on human cerebral blood flow. Psychopharmacology (Berl) 208:575–584

    Article  CAS  Google Scholar 

  • Sassano-Higgins S, Baron D, Juarez G, Esmaili N, Gold M (2016) A review of ketamine abuse and diversion. Depress Anxiety 33:718–727

    Article  CAS  PubMed  Google Scholar 

  • Schmaal L, Hibar D, Sämann P, Hall G, Baune B, Jahanshad N, Cheung J, Van Erp T, Bos D, Ikram M (2017) Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA major depressive disorder working group. Mol Psychiatry 22:900

    Article  CAS  PubMed  Google Scholar 

  • Seidman LJ, Valera EM, Makris N (2005) Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1263–1272

    Article  PubMed  Google Scholar 

  • Sparks B, Friedman S, Shaw D, Aylward EH, Echelard D, Artru A, Maravilla K, Giedd J, Munson J, Dawson G (2002) Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59:184–192

    Article  CAS  PubMed  Google Scholar 

  • Stoeckel LE, Garrison KA, Ghosh SS, Wighton P, Hanlon CA, Gilman JM, Greer S, Turk-Browne NB, deBettencourt MT, Scheinost D (2014) Optimizing real time fMRI neurofeedback for therapeutic discovery and development. NeuroImage Clin 5:245–255

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, Larson ER (1999) Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 56:254–260

    Article  CAS  PubMed  Google Scholar 

  • Sun L, Li Q, Li Q, Zhang Y, Liu D, Jiang H, Pan F, Yew DT (2014) Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys. Addict Biol 19:185–194

    Article  CAS  PubMed  Google Scholar 

  • Sutherland MT, McHugh MJ, Pariyadath V, Stein EA (2012) Resting state functional connectivity in addiction: lessons learned and a road ahead. Neuroimage 62:2281–2295

    Article  PubMed  Google Scholar 

  • Symms M, Jäger H, Schmierer K, Yousry T (2004) A review of structural magnetic resonance neuroimaging. J Neurol Neurosurg Psychiatry 75:1235–1244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang W, Liang H, Lau C, Tang A, Ungvari GS (2013) Relationship between cognitive impairment and depressive symptoms in current ketamine users. J Stud Alcohol Drugs 74:460–468

    Article  CAS  PubMed  Google Scholar 

  • Tang J, Liao Y, He H, Deng Q, Zhang G, Qi C, Cui H, Jiao B, Yang M, Feng Z (2015a) Sleeping problems in Chinese illicit drug dependent subjects. BMC Psychiatry 15:28

    Article  PubMed  PubMed Central  Google Scholar 

  • Tang J, Morgan HL, Liao Y, Corlett PR, Wang D, Li H, Tang Y, Chen J, Liu T, Hao W (2015b) Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia. Psychopharmacology (Berl) 232:1515–1526

    Article  CAS  Google Scholar 

  • Tsai TH, Cha TL, Lin CM, Tsao CW, Tang SH, Chuang FP, Wu ST, Sun GH, Yu DS, Chang SY (2009) Ketamine-associated bladder dysfunction. Int J Urol 16:826–829

    Article  CAS  PubMed  Google Scholar 

  • Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B, Krystal JH, Sanacora G (2011) The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS. Psychiatry Res Neuroimaging 191:122–127

    Article  CAS  Google Scholar 

  • Van Erp TG, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R (2018) Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the enhancing neuro imaging genetics through meta analysis (ENIGMA) consortium. Biol Psychiatry 84:644–654

    Article  PubMed  PubMed Central  Google Scholar 

  • Volkow ND, Wang G-J, Fowler JS, Tomasi D, Baler R (2014) Neuroimaging of addiction. In: Imaging of the human brain in health and disease. Elsevier, Amsterdam, pp 1–26

    Google Scholar 

  • Wang C, Zheng D, Xu J, Lam W, Yew D (2013) Brain damages in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat 7:23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wood R, Bassett K, Foerster T, Spry C, Tong L (2012) 1.5 tesla magnetic resonance imaging scanners compared with 3.0 tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness. CADTH Technol Overviews 2:e2201

    CAS  Google Scholar 

  • Yang Y, Cui Y, Sang K, Dong Y, Ni Z, Ma S, Hu H (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554:317

    Article  CAS  PubMed  Google Scholar 

  • Yeung L, Wai MS, Fan M, Mak Y, Lam W, Li Z, Lu G, Yew DT (2010) Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine. Toxicol Lett 193:189–193

    Article  CAS  PubMed  Google Scholar 

  • Young LE, Bartram D, Diamond MJ, Gregg AS, Jones R (1993) Clinical evaluation of an infusion of xylazine, guaifenesin and ketamine for maintenance of anaesthesia in horses. Equine Vet J 25:115–119

    Article  CAS  PubMed  Google Scholar 

  • Yu H, Li Q, Wang D, Shi L, Lu G, Sun L, Wang L, Zhu W, Mak YT, Wong N (2012) Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI). Neurotoxicology 33:70–77

    Article  PubMed  CAS  Google Scholar 

  • Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zou X, Patterson TA, Sadovova N, Twaddle NC, Doerge DR, Zhang X, Fu X, Hanig JP, Paule MG, Slikker W (2009) Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci 108:149–158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Liao, Y., Hao, W. (2020). Brain Imaging of Ketamine Abusers. In: Hashimoto, K., Ide, S., Ikeda, K. (eds) Ketamine. Springer, Singapore. https://doi.org/10.1007/978-981-15-2902-3_2

Download citation

Publish with us

Policies and ethics